Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. IDEXX Laboratories, Inc.
  6. Summary
    IDXX   US45168D1046

IDEXX LABORATORIES, INC.

(IDXX)
  Report
Delayed Nasdaq  -  04:00:00 2023-06-09 pm EDT
450.87 USD   -0.47%
05/31Transcript : IDEXX Laboratories, Inc. Presents at Stifel 2023 Jaws & Paws Conference, May-31-2023 01:15 PM
CI
05/22Insider Sell: Idexx Laboratories
MT
05/17IDEXX LABORATORIES, INC. : Shareholders meeting voting results
CO
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/05/2023 06/06/2023 06/07/2023 06/08/2023 06/09/2023 Date
465.28(c) 459.53(c) 450.7(c) 453(c) 450.87(c) Last
416 823 371 655 554 107 386 935 359 791 Volume
-1.18% -1.24% -1.92% +0.51% -0.47% Change
More quotes
Estimated financial data (e) (USD)
Sales 2023 3 668 M - -
Net income 2023 806 M - -
Net Debt 2023 868 M - -
P/E ratio 2023 46,9x
Yield 2023 -
Sales 2024 4 047 M - -
Net income 2024 913 M - -
Net Debt 2024 689 M - -
P/E ratio 2024 40,8x
Yield 2024 -
Capitalization 37 424 M 37 424 M -
EV / Sales 2023 10,4x
EV / Sales 2024 9,42x
Nbr of Employees 10 780
Free-Float 76,4%
More Financials
Company
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (90.8%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (4.2%): solutions that help detect infectious... 
Read more
More about the company
Ratings of IDEXX Laboratories, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about IDEXX LABORATORIES, INC.
05/31Transcript : IDEXX Laboratories, Inc. Presents at Stifel 2023 Jaws & Paws Con..
CI
05/22Insider Sell: Idexx Laboratories
MT
05/17IDEXX LABORATORIES, INC. : Shareholders meeting voting results
CO
05/10IDEXX Laboratories to Present at Stifel Conference and Announces 2023 Investor Day
BU
05/08Insider Sell: Idexx Laboratories
MT
05/08Insider Sell: Idexx Laboratories
MT
05/08Insider Sell: Idexx Laboratories
MT
05/02Health Care Down Slightly After Pfizer Earnings -- Health Care Roundup
DJ
05/02IDEXX LABORATORIES INC /DE Management's Discussion and Analysis of Financial Condition..
AQ
05/02Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13..
CI
05/02Ecolab 1Q Net Up on Rising Demand
DJ
05/02Transcript : IDEXX Laboratories, Inc., Q1 2023 Earnings Call, May 02, 2023
CI
05/02IDEXX Laboratories Q1 Adjusted Earnings, Revenue Increase
MT
05/02Idexx : Q1 Earnings Snapshot
AQ
05/02Earnings Flash (IDXX) IDEXX LABORATORIES Posts Q1 Revenue $900.2M, vs. Street Est of $8..
MT
More news
News in other languages on IDEXX LABORATORIES, INC.
05/22Vente d'initié : Idexx Laboratories
05/08Vente d'initié : Idexx Laboratories
05/08Vente d'initié : Idexx Laboratories
05/08Vente d'initié : Idexx Laboratories
05/03Valores destacados al cierre del mercado norteamericano
More news
Analyst Recommendations on IDEXX LABORATORIES, INC.
More recommendations
ETFs positioned on IDEXX LABORATORIES, INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Invesco DWA Healthcare Momentum ETF - USD4.61%0.39%United_States
First Trust ISE Water Index Fund ETF - USD4.2%1.45%North America
IShares U.S. Medical Devices ETF - USD3.44%-1.04%United_States
IShares US Medical Devices (Acc) - USD3.19%0.28%-NC
BMO Equal Weight US Health Care Index ETF - CAD1.81%0.00%United_States
More ETFs positioned on IDEXX LABORATORIES, INC.
Chart IDEXX LABORATORIES, INC.
Duration : Period :
IDEXX Laboratories, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IDEXX LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 450,87 $
Average target price 540,80 $
Spread / Average Target 19,9%
EPS Revisions
Managers and Directors
Jonathan J. Mazelsky President, Chief Executive Officer & Director
Brian Patrick McKeon Chief Financial Officer, Treasurer & Executive VP
Lawrence D. Kingsley Non-Executive Chairman
Ken Grady Chief Information Officer & Senior VP
Murthy Yerramilli Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
IDEXX LABORATORIES, INC.11.04%37 424
ABBOTT LABORATORIES-8.21%176 833
MEDTRONIC PLC6.92%111 429
STRYKER CORPORATION13.20%106 533
ESSILORLUXOTTICA-0.82%80 364
BECTON, DICKINSON AND COMPANY-1.10%71 430
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
fermer